Crystalline hydroxyapatite/graphene oxide complex by low-temperature sol-gel synthesis and its characterization

This study presents a method for synthesizing hydroxyapatite (HA) with high crystallinity at low temperatures using a small amount of graphene oxide (GO), and the characters of produced GO/crystalline HA complex was investigated. The morphology and components of the synthesized HA (i.e., HA/GO) were analyzed through scanning electron microscopy, X-ray diffraction and transmission electron microscopy; additionally, the yield of the HA/GO was assessed. The HA/GO results were analyzed by comparing them with those obtained using HA synthesized without GO as a control group. A yield of similar to 4 mg of HA/GO was attained by the use of 100 mu g of GO, demonstrating 20% improvement over the control group. The crystal phase analysis confirmed that crystalline HA of fine quality with nano-size was simply synthesized without intermediate phases using adding a small amount of GO, and the synthesized HA without GO is consist of intermediate phases (brushite and octacalcium phosphate) and hydroxyapatite. Biological characteristics of HA/GO were assessed through the behavioral analysis of mesenchymal stem cell attachment, proliferation, differentiation, and its protein adhesion capacity. HA/GO exhibited excellent biocompatibility and osteogenic differentiation behavior together with better protein adhesion ability than HA. These results demonstrate potential of HA/GO for application in bone tissue engineering. Thus, HA/GO can be developed as a biomimic biocomposite by combining it with bioactive molecules such as growth factors.

Automated summary

This study introduces a method for synthesizing high quality and nano-sized hydroxyapatite with graphene oxide, resulting in a 20% increase in yield compared to hydroxyapatite synthesized without graphene oxide. Biological analysis shows that the HA/GO complex exhibits excellent biocompatibility, osteogenic differentiation behavior, and better protein adhesion capacity than pure HA. These results suggest the potential application of HA/GO in bone tissue engineering, especially when combined with bioactive molecules such as growth factors.